Jan‐Willem C. Alffenaar

Author

University Medical Center Groningen ORCID

Also Known As

Alffenaar JW, Alffenaar, Jan-Willem, Cornely, Oliver A, David Burger, Didi, Domingo Juan Palmero, J W C Alffenaar, J. Alffenaar, J. W. Alffenaar, J. W. C. Alffenaar

469

Publications

15.4K

Citations

H-Index

109

Concepts

All Affiliations

University Medical Center Groningen University of Groningen The University of Sydney Westmead Hospital Radboud University Nijmegen

About

Jan‐Willem C. Alffenaar is an author at University Medical Center Groningen specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	59	2.9K
2	Health Sciences	10	10	753
3	Public Health	3	3	118
4	Engineering	1	1	10
5	Natural Sciences	1	1	187

Jan‐Willem C. Alffenaar

164

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study Keertan Dheda, Martin Enwerem, Rodolfo Romero Leyet, European Respiratory Journal Pulmonary TuberculosisHealth SciencesBedaquiline-containing RegimensMulticentre StudyPharmacology	2017	294
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020 Giovanni Battista Migliori, Pei Min Thong, Onno W. Akkerman, Emerging infectious diseases	2020	216
Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention Thi Van Anh Nguyen, Richard Anthony, Anne‐Laure Bañuls, Clinical Infectious Diseases New DrugMedicinal ChemistryMedicineNatural SciencesMolecular Biology	2017	187
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report Edvardas Danila, Andrei Maryandyshev, Margareth Pretti Dalcolmo, European Respiratory Journal	2019	168
Voriconazole metabolism is influenced by severe inflammation: a prospective study Anette Veringa, Mendy ter Avest, Lambert F. R. Span, Journal of Antimicrobial Chemotherapy	2016	149
Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery Remco A. Koster, Jan‐Willem C. Alffenaar, Ben Greijdanus, Talanta Dried Blood SpotsMedicineImmunosuppressive TherapyImmunologyHematology	2013	137
Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume Dinh Hoa Vu, Remco A. Koster, Jan‐Willem C. Alffenaar, Journal of Chromatography B Laboratory HematologyDried Blood SpotsMedicineBioanalysisHematology	2011	132
Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid and Plasma in Patients with Tuberculous Meningitis Jan‐Willem C. Alffenaar, Richard van Altena, H. J. Bökkerink, Clinical Infectious Diseases AntibioticsMedicineCerebrospinal FluidFull PlasmaTuberculosis	2009	108
Inflammation Is Associated with Voriconazole Trough Concentrations Marjolijn J. P. van Wanrooy, Lambert F. R. Span, Michael G. G. Rodgers, Antimicrobial Agents and Chemotherapy	2014	103
Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS Jan‐Willem C. Alffenaar, A. Mireille A. Wessels, Kai van Hateren, Journal of Chromatography B Therapeutic Drug MonitoringPharmaceutical ScienceAntifungal AgentBioassay-guided IsolationAntifungal Agents	2009	101

Page 1